Safety and efficacy of AMG 386 in combination with sunitinib in patients with metastatic renal cell carcinoma (mRCC) in an open-label multicenter phase II study.
暂无分享,去创建一个
A. Ravaud | M. Atkins | P. Tomczak | G. Gravis | D. Weinreich | M. Puhlmann | K. Drosik | K. Kracht | T. Demkow